Q32 BIO INC
QTTB · NASDAQ
更新于 2026-10-14 09:06:44
- 今日最高
- $8.69
- 今日最低
- $7.89
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K线图趋势，实际资料以交易页为准
关键数据
- 昨日开盘价
- $8.64
- 昨日收盘价
- $8.74
- 成交量
- 68.45万
- 市值
- $2.6亿
- 本益比（P/E）
- 8.81X
- 每股收益（EPS）
- $2.28
昨日价格区间
52周价格区间
公司概况
- 板块
- HEALTHCARE
- 行业
- Biotechnology
- 子行业
- BIOTECHNOLOGY
- 总部
- 830 WINTER STREET, WALTHAM, MA, UNITED STATES, 02451
- 国家
- US
- 上市日期
- 2018-03-28
- 财年截止
- December
- 流通股数
- 2976万
- CIK
- 0001661998
- 官方网址
- www.q32bio.com
Q32 Bio Inc. (QTTB) is a pioneering biotechnology firm focused on the development of advanced antibody-based therapies for autoimmune diseases and immune response optimization. Leveraging its proprietary technology platform, the company is building a robust pipeline of therapeutic candidates designed to restore immune balance and tackle significant unmet medical needs. Guided by a seasoned management team and reinforced by strategic collaborations, Q32 Bio is well-positioned to make impactful contributions to healthcare and generate substantial long-term value for its shareholders through dedicated research and development initiatives.
财务指标
营业收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$5373.7万
2025-09-30
$0
营业支出
2026-06-30
$903.3万
2026-03-31
$772.2万
2025-12-31
$785.8万
2025-09-30
$757.7万
净利润
2026-06-30
-$894.6万
2026-03-31
-$760.9万
2025-12-31
$5773万
2025-09-30
-$738.9万
净利润率
2026-06-30
--
2026-03-31
--
2025-12-31
107.43%
2025-09-30
--
每股收益
2026-06-30
$-0.44
2026-03-31
$-0.54
2025-12-31
$4.58
2025-09-30
$-0.60
息税折旧摊销前利润
2026-06-30
-$886.1万
2026-03-31
-$763.2万
2025-12-31
$5802万
2025-09-30
-$699.8万
有效税率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| 项目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 营业收入 | $0 | $0 | $5373.7万 | $0 |
| 营业支出 | $903.3万 | $772.2万 | $785.8万 | $757.7万 |
| 净利润 | -$894.6万 | -$760.9万 | $5773万 | -$738.9万 |
| 净利润率 | -- | -- | 107.43% | -- |
| 每股收益 | $-0.44 | $-0.54 | $4.58 | $-0.60 |
| 息税折旧摊销前利润 | -$886.1万 | -$763.2万 | $5802万 | -$699.8万 |
| 有效税率 | -- | -- | -- | -- |
常见问题
风险提示
股价可能大幅波动，短时间内可能出现显著涨跌。 数字资产与衍生品交易可能涉及杠杆、流动性等额外风险。 本页内容仅供参考，不构成任何投资建议。 产品可用性与访问可能因地区及适用法规而异。